AGTC News and Press, Applied Genetic Technologies Corporation From 05/26/21

AGTC Appoints Regulatory Expert, Janet C. Rae, RAC, as SVP of Global Regulatory and Quality GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 26, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of a...

The "Tesla Test" looks for the rare combination of forensic scores that preceded a 40% drop in TSLA stock in a prior ad-hoc study forecasting many other stock declines since. This ongoing test of 22 adverse fundamental forensic and value ratios across four accounting algorithms resume...

Buy Dexcom, Abiomed, and Eargo on the dip: William BlairDexCom (DXCM), Abiomed (ABMD), and Eargo (EAR) have underperformed in the year so far, but citing their quarterly reports, William Blair’s Margaret Kaczor thinks the group of med-tech stocks are attractive buys on the pullback.Des...

Applied Genetic Technologies Corporation (AGTC) Q3 2021 Earnings Conference Call May 17, 2021 4:30 PM ET Company Participants Sue Washer – President and Chief Executive Officer Stephen Potter – Chief Business Officer Bill Sullivan – Chief Financial Officer Mark Shearman &...

Applied Genetic (AGTC): Q3 GAAP EPS of -$0.40 beats by $0.02.Press Release For further details see: Applied Genetic EPS beats by $0.02

- Reported 50% response rate in visual sensitivity among patients in highest dose groups in ongoing Phase 1/2 clinical trial of its XLRP gene therapy candidate for patients who met inclusion criteria for Skyline and Vista trials - - Company on track to provide multiple data read...

Concept Companies Breaks Ground on Expansion for AGTC in Alachua's Foundation Park PR Newswire GAINESVILLE, Fla. , May 14, 2021 /PRNewswire/ -- Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has exec...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s the end of the week and we’re closing it out right here at InvestorPlace with coverage of the most talked-about penny stocks on Reddit for Friday. Source: Shutterstock But don’t just jump...

Otonomy (OTIC) announces preclinical proof-of-concept results for OTO-825 at the ASGCT Annual Meeting. OTO-825 is an AAV-mediated gene therapy developed in collaboration with Applied Genetic Technologies Corporation (AGTC).The results demonstrate that a single administration of OTO-825 rescue...

SAN DIEGO, May 14, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced preclinical proof-of-concept results for OTO-825 presented at the American Society of Gene &...